Researcher
Rik Gijsbers
- Disciplines:Molecular medicine
Affiliations
- Molecular Virology and Gene Therapy (Division)
Member
From1 Oct 2005 → Today - Laboratory of Virology and Chemotherapy (Rega Institute) (Division)
Member
From1 Aug 2003 → 30 Sep 2005
Projects
1 - 10 of 35
- Gene editing for cystic fibrosis - tackling the translatability hurdleFrom10 Jan 2024 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Organoid technologies for disease modeling, drug discovery and development for rare diseasesFrom1 Jan 2024 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Using iPS cells to regenerate muscleFrom26 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The GEne Therapy INnovation Training NetworkFrom1 Sep 2023 → TodayFunding: HORIZON.1.2 - Marie Skłodowska-Curie-actions (MSCA)
- Downstream bioseparation with membrane technologyFrom25 Aug 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- The GEne Therapy INnovation Training NetworkFrom1 Apr 2023 → TodayFunding: BOF - projects
- Building a proprietary platform for DNA-antibody based therapeuticsFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- Gene therapeutic intervention during ex vivo lung perfusion as a platform to modulate human lung diseaseFrom1 Oct 2022 → TodayFunding: FWO Strategic Basic Research Grant
- Next Steps in HBV Vaccine Research: Novel Small Animal Models for HBV Infection and Innovative Microneedle Patch-Based Vaccine Delivery MethodsFrom1 Oct 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Predicting metastasis formation based on cancer cells with a distinct energy metabolismFrom1 Oct 2022 → TodayFunding: BOF - projects
Publications
1 - 10 of 166
- Current Status and Prospects of Viral Vector-Based Gene Therapy to Treat Kidney Diseases.(2024)
Authors: Louise Medaer, Rik Gijsbers
Pages: 139 - 150 - Evaluation of the efficacy of cystinosin supplementation through CTNS mRNA delivery in experimental models for cystinosis(2023)
Authors: Tjessa Bondue, Sante Princiero Berlingerio, Rik Gijsbers
- Tailoring stimuli-responsive PVDF-based copolymer membrane with engineered pore structure for efficient antibody purification(2023)
Authors: Jeroen Wagemans, Samuel Eyley, Wim Thielemans, Rik Gijsbers, Mario Smet, Xing Yang
- Nanoblades allow high-level genome editing in murine and human organoids(2023)
Authors: Mattijs Bulcaen, Marjolein Ensinck, François Vermeulen, Susana Neves Rocha, Louise Medaer, Rik Gijsbers, Marianne Carlon
- Recombinant Adenoassociated Viral Vector 2/8 Model Of Interleukin 6 Mediated Chronic Inflammation(2023)
Authors: Johanna Jacobs, Chris Van den Haute, Rik Gijsbers
- Spatially resolved intracellular delivery of molecules at single cell level on a microelectrode array(2023)
Authors: Bastien Duckert, Liesbet Lagae, Rik Gijsbers, Frederik De Smet
Number of pages: 124 - VEGF overexpressed mesoangioblasts enhance urethral and vaginal recovery following simulated vaginal birth in rats(2023)
Authors: Marina Monteiro Carvalho Mori Da, Ben van der Veer, Laura Cattani, Kian Koh, Greetje Vande Velde, Rik Gijsbers, Maarten Albersen, Maurilio Sampaolesi, Jan Deprest
- Case report: Myocarditis in congenital STAT1 gain-of function(2023)
Authors: Frederik Staels, Willem Roosens, Leen Moens, Jan Bogaert, Rik Gijsbers, Xavier Bossuyt, Glynis Frans, Stephanie Humblet-Baron, Isabelle Meyts, Lucas Van Aelst, et al.
- Nanoblades allow high-level genome editing in organoids(2022)
Authors: Mattijs Bulcaen, Marjolein Ensinck, Louise Medaer, Rik Gijsbers, Marianne Carlon
Pages: A8 - A8 - Extracellular vesicle-derived miRNAs improve stem cell-based therapeutic approaches in muscle wasting conditions(2022)
Authors: Laura Yedigaryan, Ben van der Veer, Rik Gijsbers, Kian Koh, Liesbeth De Waele, Gunnar Buyse, Rita Derua, Maurilio Sampaolesi
Patents
1 - 4 of 4